BSE filing, NSE: SUNDRMFAST. Summary written from the filing by ALFA Finder's alert engine.
Sundram Fasteners Ltd: key numbers
- Share price
- ₹1,080.20
- Market cap
- ₹22,698 Cr
- Revenue (annual)
- ₹6,289 Cr
- Net profit (annual)
- ₹591.2 Cr
- P/E (TTM)
- 35.9×Sector 30.9×
- Promoter holding
- 46.95%+0.00% QoQ
- FII holding
- 11.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sundram Fasteners Ltd
All →Sundram Fasteners Dividend
Sundram Fasteners declared an interim dividend of Rs. 4.05 per share for FY 2026-27 at its 28 October 2026 board meeting. Record date is 6 November 2026 and payment on 23 November 2026.
Sundram Fasteners Q2 FY27 Results: Net Profit ₹172.6 Cr, Up 13.0% YoY
Sundram Fasteners Ltd reported revenue from operations of ₹1,984 Cr (+30.5% YoY) and net profit of ₹172.6 Cr (+13.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹172.6 Cr · +13.0% YoY
Sundram Fasteners Board Meeting Date
Sundram Fasteners schedules a board meeting on October 28, 2026, to approve unaudited financial results and consider an interim dividend.
Sundram Fasteners Other Announcement
Sundram Fasteners filed its quarterly shareholding pattern. The company reclassified three entities from the promoter group to public category per SEBI Regulation 31A.
Sundram Fasteners Promoter Reclassification
Sundram Fasteners received NSE and BSE approval to reclassify three Promoter Group entities as Public. The move under Reg 31A reduces promoter holding to Nil.
Sundram Fasteners Credit Rating
Sundram Fasteners Limited has received a re-affirmation of its 'CRISIL A1+' rating for its short-term debt and commercial paper instruments from CRISIL Ratings Limited.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.